Revolution Medicines, Inc. Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Revolution Medicines, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Revolution Medicines, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$216M, a 20.2% decline year-over-year.
  • Revolution Medicines, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$690M, a 41.5% decline year-over-year.
  • Revolution Medicines, Inc. annual Operating Income (Loss) for 2024 was -$690M, a 41.5% decline from 2023.
  • Revolution Medicines, Inc. annual Operating Income (Loss) for 2023 was -$487M, a 88.6% decline from 2022.
  • Revolution Medicines, Inc. annual Operating Income (Loss) for 2022 was -$258M, a 37.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$690M -$202M -41.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$487M -$229M -88.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$258M -$70.3M -37.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 -$188M -$77.3M -69.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$111M -$56.6M -105% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$54.1M -$13.8M -34.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$40.3M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.